Stroke prevention in atrial fibrillation patients with a single stroke risk factor: Clinical decision-making and guideline recommendations: A case report and comparative analysis of the European Society of Cardiology (ESC) and American Heart Association/American College of Cardiology/Heart Rhythm Society (AHA/ACC/HRS) guidelines on the management of atrial fibrillation-Reference-Cited by-同舟云学术

Stroke prevention in atrial fibrillation patients with a single stroke risk factor: Clinical decision-making and guideline recommendations: A case report and comparative analysis of the European Society of Cardiology (ESC) and American Heart Association/American College of Cardiology/Heart Rhythm Society (AHA/ACC/HRS) guidelines on the management of atrial fibrillation

Published:2016 Issue:2 Volume:35 Page:18-22
ISSN:1821-4835
Container-title:Srce i krvni sudovi
language:en
Short-container-title:Srce i krvni sudovi

Author:

Potpara Tatjana,Jokić Vera,Mijatović Zlatiborka

Publisher

Centre for Evaluation in Education and Science (CEON/CEES)

Link

https://scindeks-clanci.ceon.rs/data/pdf/1821-4835/2016/1821-48351601018P.pdf

Reference41 articles.

1. Camm AJ, Lip GY, De Caterina R, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. European heart journal. 2012;33(21):2719-2747.;

2. Chugh SS, Blackshear JL, Shen WK, Hammill SC, Gersh BJ. Epidemiology and natural history of atrial fibrillation: clinical implications. Journal of the American College of Cardiology. 2001;37(2):371-378.;

3. Fang MC, Go AS, Chang Y, et al. Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants. Stroke; a journal of cerebral circulation. 2012;43(7):1795-1799.;

4. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Annals of internal medicine. 2007;146(12):857-867.;

5. Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. The New England journal of medicine. 2009;361(12):1139-1151.;